ID: ALA3588911

Max Phase: Preclinical

Molecular Formula: C15H21N3

Molecular Weight: 243.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1Cn1ccnc1CNC(C)C

Standard InChI:  InChI=1S/C15H21N3/c1-12(2)17-10-15-16-8-9-18(15)11-14-7-5-4-6-13(14)3/h4-9,12,17H,10-11H2,1-3H3

Standard InChI Key:  IHXSUUAPXBDLCV-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-2c adrenergic receptor 4876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.35Molecular Weight (Monoisotopic): 243.1735AlogP: 2.74#Rotatable Bonds: 5
Polar Surface Area: 29.85Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 2.72CX LogD: 1.93
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -1.65

References

1. Szőllősi E, Bobok A, Kiss L, Vass M, Kurkó D, Kolok S, Visegrády A, Keserű GM..  (2015)  Cell-based and virtual fragment screening for adrenergic α2C receptor agonists.,  23  (14): [PMID:25648685] [10.1016/j.bmc.2015.01.013]

Source